Shares of Stem, Inc. (NYSE:STEM – Get Free Report) have received an average rating of “Reduce” from the seven research firms that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation and six have issued a hold recommendation on the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $16.00.
A number of research firms have recently commented on STEM. Susquehanna upped their price objective on shares of Stem from $12.00 to $21.00 and gave the company a “neutral” rating in a research note on Monday, October 13th. UBS Group upped their price target on shares of Stem from $16.00 to $18.00 and gave the stock a “neutral” rating in a research report on Friday, October 31st. Roth Capital set a $23.00 price target on shares of Stem and gave the company a “neutral” rating in a report on Thursday, October 30th. Barclays reissued a “reduce” rating and set a $18.00 price objective (up from $13.00) on shares of Stem in a research note on Friday, October 31st. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Stem in a research report on Monday, December 15th.
View Our Latest Stock Report on Stem
Stem Stock Down 0.5%
Stem (NYSE:STEM – Get Free Report) last released its earnings results on Thursday, October 30th. The company reported ($2.84) EPS for the quarter, missing the consensus estimate of ($1.85) by ($0.99). The company had revenue of $38.24 million during the quarter, compared to analysts’ expectations of $39.07 million. Equities research analysts anticipate that Stem will post -0.52 EPS for the current year.
Trending Headlines about Stem
Here are the key news stories impacting Stem this week:
- Neutral Sentiment: Several press items refer to “STEM” in education and life-science contexts that are not related to Stem, Inc.’s energy storage/AI business; they are unlikely to affect the company’s fundamentals. Scientists show targeting cancer stem cells can prevent gastric cancer recurrence
- Neutral Sentiment: Multiple local K–12 and district stories about new or relocated STEM schools (Bio-Med Science Academy, Fayette County, Lufkin ISD, Goldsboro) are education items and do not pertain to Stem, Inc.’s business. Bio-Med Science Academy STEM School to relocate to Ohio college campus Fayette County board votes to merge STEM academies Lufkin ISD introduces STEM school Goldsboro STEM school cuts ties with extra property
- Neutral Sentiment: Other unrelated items (stem-cell research resources, unlicensed clinics, bicycle component release, corporate donation to VR STEM labs) are sector- or consumer-focused and don’t affect Stem, Inc.’s financials. Researchers identify 166 human pluripotent stem cell lines 3 charged for performing unlicensed stem cell operations in Draper Cane Creek Drops Colorful New Stem Faceplates Diamondback Energy invests to expand VR STEM labs
- Negative Sentiment: Directly relevant to investors: brokerages have assigned Stem, Inc. an average “Reduce” recommendation this week — a formal analyst downgrade that likely put near-term selling pressure on the stock. This appears to be the main immediate news driver for the share weakness, compounded by Stem’s recent quarter where EPS and revenue missed consensus and the company remains loss-making. Stem, Inc. (NYSE:STEM) Given Average Recommendation of “Reduce” by Brokerages
Insider Activity at Stem
In other news, CAO Rahul Shukla sold 3,674 shares of Stem stock in a transaction dated Tuesday, November 18th. The stock was sold at an average price of $16.21, for a total value of $59,555.54. The transaction was disclosed in a document filed with the SEC, which is available through this link. 5.10% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the business. AQR Capital Management LLC increased its position in shares of Stem by 505.8% in the first quarter. AQR Capital Management LLC now owns 1,482,790 shares of the company’s stock worth $519,000 after acquiring an additional 1,238,012 shares in the last quarter. Bank of America Corp DE boosted its position in Stem by 104.0% during the 3rd quarter. Bank of America Corp DE now owns 217,871 shares of the company’s stock worth $3,817,000 after purchasing an additional 111,068 shares during the period. Charles Schwab Investment Management Inc. increased its holdings in Stem by 22.0% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 444,053 shares of the company’s stock valued at $156,000 after purchasing an additional 80,000 shares in the last quarter. Two Sigma Investments LP raised its position in Stem by 461.9% in the third quarter. Two Sigma Investments LP now owns 94,045 shares of the company’s stock valued at $1,648,000 after purchasing an additional 77,307 shares during the period. Finally, Hsbc Holdings PLC lifted its stake in shares of Stem by 5.6% during the first quarter. Hsbc Holdings PLC now owns 873,282 shares of the company’s stock worth $307,000 after purchasing an additional 46,573 shares in the last quarter. 61.63% of the stock is owned by institutional investors and hedge funds.
Stem Company Profile
Stem, Inc is a technology company specializing in AI-driven energy storage and optimization solutions for commercial, industrial and utility customers. The company delivers integrated hardware and software systems that enable clients to manage energy consumption, reduce peak demand charges and provide ancillary services to the power grid. By combining battery storage hardware with advanced machine-learning algorithms, Stem helps organizations align energy usage with cost-saving opportunities while supporting grid reliability and renewable integration.
At the core of Stem’s offering is its Athena software platform, which uses real-time data and predictive analytics to forecast energy needs and automatically dispatch stored energy when it is most valuable.
Recommended Stories
- Five stocks we like better than Stem
- What does consumer price index measure?
- These 3 Banks Are Rallying Into Year-End, But Will It Continue?
- Why Invest in High-Yield Dividend Stocks?
- 3 Surging Stocks Just Got the Ultimate Stamp of Approval From the S&P 500
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- This ETF Caught a Major Tailwind After the Fed’s Rate Cut
Receive News & Ratings for Stem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stem and related companies with MarketBeat.com's FREE daily email newsletter.
